A new study reveals a troubling trend in American children's health, showing a significant increase in chronic conditions such as obesity, depression, and anxiety since 2007. Experts warn of worsening outcomes due to healthcare disparities and policy changes.
South-central Texas is battling devastating floods with at least 95 confirmed dead, including 28 children. As rescue operations stretch into a fourth day, communities rally to support recovery efforts for the victims.
A recent study reveals that young people in Hong Kong who skip breakfast may be more prone to depressive symptoms and impulsive behavior. The findings highlight the importance of regular breakfast consumption for mental well-being.
Tropical Depression Three is set to strengthen into Tropical Storm Chantal, bringing rain, gusty winds, and rip currents to the Southeast coast this holiday weekend. Stay prepared and have a plan B for outdoor activities!
This week in science, the enigmatic Dragon Man is identified, revealing secrets of our evolutionary past. Additionally, researchers inch closer to locating the universe's elusive missing matter, while groundbreaking studies on psilocybin show promise for long-term depression relief.
A groundbreaking study reveals that teens with addictive screen use patterns face significantly higher risks of suicidal thoughts and mental health issues. Unlike total screen time, it's the compulsive nature of use that predicts these outcomes. Early interventions are crucial!
A new study indicates that a single dose of psilocybin can alleviate depression for up to five years, offering hope for those with major depressive disorder. This groundbreaking research highlights the potential of psychedelics in mental health treatment.
Recent research suggests that psilocybin, the active compound in magic mushrooms, may alleviate depressive episodes in bipolar II disorder, showing promise without triggering mania. The trial found significant improvements among participants, indicating a potential new treatment avenue.
A new phase 2 trial reveals that a single dose of psilocybin, combined with psychological support, significantly reduces depression in over half of cancer patients, lasting up to two years.
A new clinical trial shows that a single dose of psilocybin can significantly reduce depression and anxiety in cancer patients. With promising long-term results, this therapy offers hope for many.
